NFE2L2 and glomerulosclerosis: Interestingly, a recent report suggests that using an activator of nuclear factor erythroid 2-related factor 2 (Nrf2) in the COL4α5 mouse model of AS showed the amelioration of inflammation, as well as fibrosis and glomerulosclerosis, in association with an extended lifespan [142].